3Indexed trials
drug · Product Intelligence
Placebo (semaglutide)
Pipeline Intelligence
Placebo (semaglutide): 3 indexed trials, 1 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.
1Sponsors
0Orange Book patent links
0FDA-linked events
Development evidence
NCT03574597Novo Nordisk A/S · strokePHASE3
NCT04777409Novo Nordisk A/S · alzheimersPHASE3
NCT05567796Novo Nordisk A/S · out_of_scopePHASE3
FDA / patent evidence
No FDA Orange Book product match is asserted for this intervention.
Regulatory context
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.